Market revenue in 2023 | USD 26.3 million |
Market revenue in 2030 | USD 40.2 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Biomarker services |
Fastest growing segment | Anatomic Pathology/Histology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 38.4% in 2023. Horizon Databook has segmented the Saudi Arabia central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia is estimated to grow at a significant growth rate over the forecast period owing to strong government support and advancements in laboratory technology.
The country is attempting to transition from an oil-dependent economy to a knowledge-based economy and is attracting the attention of several international pharmaceutical companies to accelerate R&D activities.
Thus, the government is involved in expanding the healthcare sector of the country. For instance, according to the Gulf Cooperation Council, Saudi Arabia spends a significant portion, about 16%, of its annual budget on healthcare and made large investments in healthcare infrastructure globally from 2010 to 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia central lab market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account